KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Change in Cash (2016 - 2025)

Astrana Health's Change in Cash history spans 16 years, with the latest figure at $124.0 million for Q3 2025.

  • For Q3 2025, Change in Cash rose 446.54% year-over-year to $124.0 million; the TTM value through Sep 2025 reached $115.7 million, up 55.59%, while the annual FY2024 figure was -$5.1 million, 182.47% down from the prior year.
  • Change in Cash for Q3 2025 was $124.0 million at Astrana Health, up from $81.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $124.0 million in Q3 2025 and bottomed at -$59.5 million in Q4 2024.
  • The 5-year median for Change in Cash is $11.9 million (2021), against an average of $14.2 million.
  • The largest annual shift saw Change in Cash tumbled 399.7% in 2024 before it surged 955.93% in 2025.
  • A 5-year view of Change in Cash shows it stood at $28.3 million in 2021, then skyrocketed by 267.15% to $104.0 million in 2022, then plummeted by 80.9% to $19.9 million in 2023, then tumbled by 399.7% to -$59.5 million in 2024, then soared by 308.23% to $124.0 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Change in Cash are $124.0 million (Q3 2025), $81.2 million (Q2 2025), and -$29.9 million (Q1 2025).